Attoquant Diagnostics is a global company providing high performance analysis of biomarkers supporting research and clinical management of hypertension. We specialize in the analytic challenges of angiotensin quantification for routine applications in clinical settings. Angiotensin-based biomarkers provide deep insights into the dynamic regulation of the Renin-Angiotensin-Aldosterone-System (RAAS).
Our latest innovation is the newly launched RAAS Triple-A™ Kit for clinical mass spectrometry.
Our vision is to globally improve hypertension control by providing a simple blood test to identify the most frequent underlying causes of uncontrolled hypertension, allowing for a personalized and more effective therapy.
Together, let’s bring hypertension management to the next level!
Company Details
- Employees
- 8
- Founded
- -
- Address
- Brehmstraße 14a, Wien,1110,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.attoquant.com
- Keywords
- 3.
- HQ
- Wien
Attoquant Diagnostics Gmbh Questions
Attoquant Diagnostics Gmbh's website is http://www.attoquant.com
Attoquant Diagnostics Gmbh's LinkedIn profile is https://at.linkedin.com/company/attoquant
Attoquant Diagnostics Gmbh has
8 employees.
View email and phone details for 8
employees at Attoquant Diagnostics Gmbh.
Attoquant Diagnostics Gmbh's industry is
Biotechnology Research
Attoquant Diagnostics Gmbh's top competitors are
Covirabio Gmbh,
Fermify,
Oncoqr Ml Gmbh,
Aposcience Ag,
Improcess Gmbh,
Gh Bioquenta Consulting E.u.,
Apeiron Biologics Ag,
Mycoplasma Biosafety,
Viennalab Diagnostics,
Panoptes Pharma Ges.m.b.h.
Attoquant Diagnostics Gmbh's categories are Biotechnology Research
Attoquant Diagnostics Gmbh's founding year is 2012
